Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Comparison of Three Prognostic Scoring Systems in a Series of 146 Cases of Chronic Myelomonocytic Leukemia (CMML): MD Anderson Prognostic Score (MDAPS), CMML-Specific Prognostic Scoring System (CPSS) and Mayo Prognostic Model

Xavier Calvo, MD, Meritxell Nomdedeu, MD PhD, Rodrigo Santacruz, MD, Núria Martínez, MD, Dolors Costa, PhD, Arturo Pereira, MD PhD, Natalia Estrada, Blanca Xicoy, MD PhD, Jordi Esteve, MD PhD, Benet Nomdedeu, MD PhD

Blood (2014) 124 (21): 4660.

https://doi.org/10.1182/blood.V124.21.4660.4660

Published: 2014

Journal Articles

Clinical Features and Prognostic Assessment in 233 Patients with Therapy-Related Myelodysplastic Syndromes: The IPSS-R Is a Powerful Predictor of Outcome

Meritxell Nomdedeu, MD PhD, Xavier Calvo, MD, Arturo Pereira, MD PhD, Dolors Costa, PhD, Carmen Pedro, MD, Maria Teresa Cedena, MD, María López-Pavía, MD, Ana Africa Martín, MD, Montserrat Martínez de Sola, MD, Brayan Marcel Merchan, MD, Maria Teresa Ardanaz, MD, Jordi Esteve, MD PhD, Francesc Cobo, MD PhD, Guillermo F. Sanz, MD PhD, Benet Nomdedeu, MD PhD

Blood (2014) 124 (21): 4636.

https://doi.org/10.1182/blood.V124.21.4636.4636

Published: 2014

Journal Articles

Treatment With G-CSF Reduces Acute Myeloid Leukemia (AML) Blasts Viability In Presence Of Bone Marrow Stroma

Meritxell Nomdedeu, MD, PhD, Marta Pratcorona, MD, Marina Díaz-Beyá, MD, Xavier Calvo, MD, Mari Carmen Lara-Castillo, PhD, Daniel Esteban, MD, Maria Rozman, MD, PhD, Dolors Costa, PhD, Jordi Esteve, MD, PhD, Ruth M. Risueño, PhD

Blood (2013) 122 (21): 1422.

https://doi.org/10.1182/blood.V122.21.1422.1422

Published: 2013

Journal Articles

Evaluation Of Two Prognostic Scoring Systems For Chronic Myelomonocytic Leukemia (CMML): CMML-Specific Prognostic Scoring System (CPSS) and MD Anderson Prognostic Score (MDAPS) In A Series Of 122 Cases Of De Novo CMML

Xavier Calvo, MD, Meritxell Nomdedeu, MD, PhD, Dolors Costa, PhD, Arturo Pereira, MD, PhD, Núria Martínez, Jordi Esteve, MD, PhD, Blanca Xicoy, MD, PhD, Benet Nomdedeu, MD, PhD

Blood (2013) 122 (21): 2810.

https://doi.org/10.1182/blood.V122.21.2810.2810

Published: 2013

Journal Articles

Conventional and Molecular Cytogenetic Responses in Patients with Myelodysplastic Syndrome (MDS) with Deletion 5q Treated with Lenalidomide.

Rita Coutinho, MD, Dolors Costa, PhD, Ana Carrió, PhD, Ana Vidal, BS, Mohammed Belkaid, MS, Elias Campo, MD, PhD, Emili Montserrat, MD, PhD, Benet Nomdedeu, MD

Blood (2009) 114 (22): 1746.

https://doi.org/10.1182/blood.V114.22.1746.1746

Published: 2009

Journal Articles

Analysis of Cytogenetic Abnormalities and Their Prognostic Impact in a Series of 145 Mantle Cell Lymphoma Cases with An Abnormal Karyotype.

Blanca Espinet, PhD, Salaverría Itziar, PhD, Sílvia Beà, PhD, Neus Ruiz-Xivillé, Olga Balagué, MD, Marta Salido, Dolors Costa, PhD, Ana E Rodriguez, Juan LuíS. García, PhD, JesúS. M.ª Hernández-Rivas, MD, PhD, M.ª José Calasanz, PhD, Ana M Ferrer, MD, PhD, Antonio Salar, MD, PhD, Ana Carrió, PhD, Natividad Polo, Jose Antonio García-Marco, MD, PhD, Alicia Domingo, MD, Eva González-Barca, MD, PhD, Vicenç Romagosa, MD, Isabel Marugán, Armando López-Guillermo, MD, PhD, Fuensanta Millá, MD, José Luís Mate, MD, PhD, Elisa Luño, MD, PhD, Carmen Sanzo, MD, PhD, Rosa Collado, MD, PhD, Isabel Oliver, Sebastià Monzó, MD, Antonio Palacín, MD, Teresa González, Francesc Sant, MD, Ramon Salinas, MD, PhD, Mª Teresa Ardanaz, MD, Llorenç Font, MD, PhD, Lourdes Escoda, MD, Lourdes Florensa, MD, PhD, Elias Campo, MD, PhD, Sergi Serrano, MD, PhD, Francesc Solé, PhD

Blood (2008) 112 (11): 1765.

https://doi.org/10.1182/blood.V112.11.1765.1765

Published: 2008

Journal Articles

Molecular Markers Predicting Clinical Outcome in Patients with Intermediate-Risk Acute Myeloid Leukemia Receiving Autologous Stem Cell Transplantation.

Jordi Esteve, MD, Susana Kalko, PhD, Montserrat Torrebadell, MD, Mireia Camos, MD, Pedro Jares, PhD, Maria Rozman, MD, Marta Pratcorona, MD, Salut Brunet, MD, Josep Nomdedeu, MD, Ana Carrio, PhD, Dolors Costa, PhD, Emili Montserrat, MD

Blood (2007) 110 (11): 604.

https://doi.org/10.1182/blood.V110.11.604.604

Published: 2007

Journal Articles

Gene Expression Profiling of Acute Myeloid Leukemia with Multilineage Dysplasia (AML-MD) Reveals a Biological Diversity Related to Underlying Cytogenetics but Also Identifies a Distinctive Profile in Normal Karyotype AML-MD.

María Rozman, MD, Susana G. Kalko, PhD, Jordi Esteve, MD, Mireia Camós, MD, Josep-Lluís Aguilar, MD, Montserrat Torrebadell, MD, Dolors Costa, PhD, Ana Carrió, PhD, Pedro Jares, PhD, Emili Montserrat, MD, Elías Campo, MD

Blood (2006) 108 (11): 2244.

https://doi.org/10.1182/blood.V108.11.2244.2244

Published: 2006

Journal Articles

Gene Expression Signature of Acute Myeloid Leukemia (AML) with T(8;16)(P11;P13) and MYST3-CREBBP Rearrangement: A Microarray Study Validated by Multiple Real-Time PCR.

Mireia Camos, MD, Jordi Esteve, MD, Dolors Colomer, PhD, Pedro Jares, PhD, Maria Rozman, MD, Neus Villamor, MD, Dolors Costa, PhD, Ana Carrio, PhD, Josep F. Nomdedeu, MD, Emili Montserrat, MD, Elias Campo, PhD

Blood (2005) 106 (11): 3009.

https://doi.org/10.1182/blood.V106.11.3009.3009

Published: 2005

NARROW

Comparison of Three Prognostic Scoring Systems in a Series of 146 Cases of Chronic Myelomonocytic Leukemia (CMML): MD Anderson Prognostic Score (MDAPS), CMML-Specific Prognostic Scoring System (CPSS) and Mayo Prognostic Model

Clinical Features and Prognostic Assessment in 233 Patients with Therapy-Related Myelodysplastic Syndromes: The IPSS-R Is a Powerful Predictor of Outcome

Treatment With G-CSF Reduces Acute Myeloid Leukemia (AML) Blasts Viability In Presence Of Bone Marrow Stroma

Evaluation Of Two Prognostic Scoring Systems For Chronic Myelomonocytic Leukemia (CMML): CMML-Specific Prognostic Scoring System (CPSS) and MD Anderson Prognostic Score (MDAPS) In A Series Of 122 Cases Of De Novo CMML

Conventional and Molecular Cytogenetic Responses in Patients with Myelodysplastic Syndrome (MDS) with Deletion 5q Treated with Lenalidomide.

Analysis of Cytogenetic Abnormalities and Their Prognostic Impact in a Series of 145 Mantle Cell Lymphoma Cases with An Abnormal Karyotype.

Molecular Markers Predicting Clinical Outcome in Patients with Intermediate-Risk Acute Myeloid Leukemia Receiving Autologous Stem Cell Transplantation.

Gene Expression Profiling of Acute Myeloid Leukemia with Multilineage Dysplasia (AML-MD) Reveals a Biological Diversity Related to Underlying Cytogenetics but Also Identifies a Distinctive Profile in Normal Karyotype AML-MD.

Gene Expression Signature of Acute Myeloid Leukemia (AML) with T(8;16)(P11;P13) and MYST3-CREBBP Rearrangement: A Microarray Study Validated by Multiple Real-Time PCR.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only